BetterLife Pharma Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
4
- Stock Symbol
-
BETR
- Investments
-
10
- Share Price
-
$0.15
- (As of Tuesday Closing)
BetterLife Pharma General Information
Description
BetterLife Pharma Inc is an emerging biotechnology company focused on developing and commercializing the compound BETR-001 to treat neuropsychiatric and neurological disorders. BETR-001 is a non-hallucinogenic and non-controlled LSD derivative in development, and it is unregulated and therefore can be self-administered. BetterLife's synthesis patent for BETR-001 eliminates regulatory hurdles, and its pending patent for composition and method of use covers treatment of depression, cluster headaches, post-traumatic stress disorder, and other neuropsychiatric and neurological disorders.
Contact Information
Website
www.abetterlifepharma.comCorporate Office
- 1275 West 6th Avenue
- Suite 300
- Vancouver, British Columbia V6H 1A6
- Canada
Corporate Office
- 1275 West 6th Avenue
- Suite 300
- Vancouver, British Columbia V6H 1A6
- Canada
BetterLife Pharma Timeline
BetterLife Pharma Stock Performance
As of 17-Nov-2026, BetterLife Pharma’s stock price is $0.15. Its current market cap is $95.7M with 651M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.15 | $0.14 | $0.03 - $0.33 | $95.7M | 651M | 423K | -$0.02 |
BetterLife Pharma Financials Summary
As of 31-Jul-2026, BetterLife Pharma has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Jul-2026 | FY 2026 31-Jan-2026 | FY 2025 31-Jan-2025 | FY 2024 31-Jan-2024 |
|---|---|---|---|---|
| EV | 36,805 | 8,839 | 14,772 | 10,047 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (2,383) | (920) | (2,393) | (2,109) |
| Net Income | (2,513) | (1,074) | (2,551) | (2,139) |
| Total Assets | 1,460 | 161 | 155 | 242 |
| Total Debt | 2,094 | 899 | 898 | 1,096 |
BetterLife Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BetterLife Pharma Patents
BetterLife Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023039682-A1 | Lsd derivatives, synthesis & method for treatment of diseases and disorders | Inactive | 20-Sep-2021 | ||
| WO-2022221942-A1 | Prevention of drug diversion | Inactive | 19-Apr-2021 | ||
| WO-2022198315-A1 | Methods of treating mental and/or mood disorders using 2-bromo-lsd alone or in combination with a mtor inhibitor | Inactive | 22-Mar-2021 | ||
| WO-2022160065-A1 | Formulations including dihydrohonokiol | Inactive | 31-Jan-2021 | ||
| WO-2022133604-A1 | Methods of treating mental or mood disorders using 2-bromo-lsd | Inactive | 22-Dec-2020 | A61P25/24 |
BetterLife Pharma Signals
BetterLife Pharma Investments & Acquisitions (10)
BetterLife Pharma’s most recent deal was a Merger/Acquisition with Transcend Biodynamics for . The deal was made on 18-Dec-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Transcend Biodynamics | 18-Dec-2020 | Merger/Acquisition | Biotechnology | ||
| Altum Pharmaceuticals | 31-Aug-2020 | Merger/Acquisition | Biotechnology | ||
| iAmHealth Distribution | 01-Dec-2019 | Merger/Acquisition | Specialty Retail | ||
| Solmic (Switzerland) | 22-Oct-2019 | Merger/Acquisition | Biotechnology | ||
| Pivot-Cartagena Joint Venture | 19-Dec-2018 | Joint Venture | Beverages |
BetterLife Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
BetterLife Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Indus Pharma | Karachi, Pakistan | 1969 |
BetterLife Pharma FAQs
-
When was BetterLife Pharma founded?
BetterLife Pharma was founded in 2002.
-
Where is BetterLife Pharma headquartered?
BetterLife Pharma is headquartered in Vancouver, Canada.
-
What is the size of BetterLife Pharma?
BetterLife Pharma has 4 total employees.
-
What industry is BetterLife Pharma in?
BetterLife Pharma’s primary industry is Drug Discovery.
-
Is BetterLife Pharma a private or public company?
BetterLife Pharma is a Public company.
-
What is BetterLife Pharma’s stock symbol?
The ticker symbol for BetterLife Pharma is BETR.
-
What is the current stock price of BetterLife Pharma?
As of 17-Nov-2026 the stock price of BetterLife Pharma is $0.15.
-
What is the current market cap of BetterLife Pharma?
The current market capitalization of BetterLife Pharma is $95.7M.
-
What is BetterLife Pharma’s annual earnings per share (EPS)?
BetterLife Pharma’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process